| CAS NO: | 1905409-39-3 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 生物活性 | Mosunetuzumab (BTCT-4465A) is a humanized, immunoglobulin G1-based bispecific antibody targetingCD20(B cells) andCD3(T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs)[1]. |
| Clinical Trial | |
| 性状 | Liquid |
| CAS 号 | 1905409-39-3 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com